Archive - June 2022
College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
Shionogi Europe and NHS England agree on antibiotic subscription model
LifeArc partners with UK Dementia Research Institute
Sage Therapeutics and Biogen Initiate Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for Zuranolone for the Potential Treatment of Major Depressive Disorder (MDD)
Update on U.S. FDA Review of Biologics License Application (BLA) for Bimekizumab – Complete Response Letter
scPharmaceuticals Inc. Announces FDA Acceptance of Furoscix New Drug Application
Travere Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Sparsentan for the Treatment of IgA Nephropathy
Cytokinetics Provides Regulatory Update Related to New Drug Application for Omecamtiv Mecarbil